Position in JNJ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$4,112,790
+$160,685 QoQ
Shares Held
16,194
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.12%
of 13F equity value
Holder Rank
#1,755
of 4,676 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TMB Capital Partners, LLC holds $9,145,872 across 7 Drug Manufacturers - General names. JNJ ranks #1 (45.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
16,194 | $4,112,790 | |
| 2 | ABBV |
AbbVie Inc.
|
13,068 | $3,288,431 | |
| 3 | LLY |
ELI LILLY & Co
|
410 | $491,766 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,085 | $396,422 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
6,630 | $382,020 | |
| 6 | PFE |
Pfizer Inc
|
9,902 | $238,440 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,868 | $236,003 |
All Filings in JNJ
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,112,790 | 16,194 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $3,952,105 | 16,168 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,314,097 | 16,014 | Shares | Sole | 2026-02-19 | |
| No filing history on record for this holder in this stock. | ||||||